Free Trial
NASDAQ:IMCC

IM Cannabis (IMCC) Stock Price, News & Analysis

IM Cannabis logo
$0.55 -0.02 (-3.83%)
Closing price 11/12/2026 04:00 PM Eastern
Extended Trading
$0.52 -0.03 (-6.15%)
As of 04:02 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About IM Cannabis Stock (NASDAQ:IMCC)

Advanced

Key Stats

Today's Range
$0.50
▼
$0.60
50-Day Range
$0.55
▼
$4.23
52-Week Range
$0.50
▼
$62.40
Volume
32,463 shs
Average Volume
56,158 shs
Market Capitalization
$547.47 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

IM Cannabis Corp. (NASDAQ: IMCC) is a medical cannabis company focused primarily on the Israeli and German markets. The company develops, sources, imports, distributes and markets medical cannabis products under the IMC brand, serving patients through pharmacies, clinics and other authorized channels.

In Israel, IM Cannabis is involved in the supply of medical cannabis products, including flower and other cannabis-based offerings, through affiliated cultivation, processing and distribution operations. In Germany, the company has participated in the importation and distribution of medical cannabis for the pharmaceutical market, subject to local regulatory requirements.

Founded in 2018, IM Cannabis historically pursued an international strategy that included operations in Canada, but it has since focused its business on its core medical cannabis activities in Israel and Germany. The company has been led by Chief Executive Officer Oren Shuster, who has overseen its development as an international cannabis operator.

AI Generated. May Contain Errors.

IM Cannabis Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
15th Percentile Overall Score

IMCC MarketRank™: 
0.766963583965 of 5 stars

IM Cannabis scored higher than 15% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    IM Cannabis has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    IM Cannabis has only been the subject of 1 research reports in the past 90 days.

  • Read more about IM Cannabis' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of IM Cannabis is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of IM Cannabis is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about IM Cannabis' valuation and earnings.
  • Percentage of Shares Shorted

    1.47% of the float of IM Cannabis has been sold short.
  • Short Interest Ratio / Days to Cover

    IM Cannabis has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in IM Cannabis has recently decreased by 59.64%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    IM Cannabis does not currently pay a dividend.

  • Dividend Growth

    IM Cannabis does not have a long track record of dividend growth.

  • News Sentiment

    IM Cannabis has a news sentiment score of 1.82. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for IM Cannabis this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, IM Cannabis insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    5.91% of the stock of IM Cannabis is held by insiders.

  • Percentage Held by Institutions

    7.68% of the stock of IM Cannabis is held by institutions.

  • Read more about IM Cannabis' insider trading history.
Receive IMCC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IM Cannabis and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IMCC Stock News Headlines

You missed yesterday's deadline…
In June 2025, a drilling crew near the Grand Canyon uncovered an energy source producing nearly eight times the output of Saudi Arabia's largest oil well, enough potential energy to power civilization for two million years. While the One Big Beautiful Bill Act stripped tax credits from solar, wind, and EVs on July 4th, this discovery was reclassified alongside oil and nuclear and secured eight years of credits. Google signed a 15-year contract, and Bill Gates committed 100 million dollars.tc pixel
See More Headlines

IMCC Stock Analysis - Frequently Asked Questions

IM Cannabis' stock was trading at $41.70 on January 1st, 2026. Since then, IMCC stock has decreased by 98.7% and is now trading at $0.5530.

IM Cannabis Corp. (NASDAQ:IMCC) posted its quarterly earnings data on Monday, March, 30th. The company reported ($25.80) earnings per share for the quarter, missing the consensus estimate of $2.58 by $28.38. The business had revenue of $11.25 million for the quarter, compared to the consensus estimate of $15.66 million.

Shares of IM Cannabis reverse split on Friday, July 12th 2024.The 1-6 reverse split was announced on Friday, July 12th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, July 12th 2024. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split.

Shares of IMCC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that IM Cannabis investors own include Cronos Group (CRON), Kraft Heinz (KHC), Tilray Brands (TLRY), Ford Motor (F), Lithium Americas (LAC), Acreage (ACRGF) and Aurora Cannabis (ACB).

Company Calendar

Last Earnings
8/13/2026
Today
11/13/2026
Next Earnings (Estimated)
11/16/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:IMCC
CIK
1792030
Fax
N/A
Employees
44
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($60.66)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$8.10 million
Net Margins
-39.62%
Pretax Margin
-40.21%
Return on Equity
N/A
Return on Assets
-58.32%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.56
Quick Ratio
0.46

Sales & Book Value

Annual Sales
$39.17 million
Price / Sales
0.01
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($14.81) per share
Price / Book
-0.04

Miscellaneous

Outstanding Shares
990,000
Free Float
933,000
Market Cap
$547.47 thousand
Optionable
Not Optionable
Beta
2.46
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (NASDAQ:IMCC) was last updated on 11/12/2026 by MarketBeat.com Staff.
From Our Partners